Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study (Neurotherapeutics, (2021), 18, 2, (1127-1136), 10.1007/s13311-020-01004-3)

Stacy A. Rudnicki; Jinsy A. Andrews; Tina Duong; Bettina M. Cockroft; Fady I. Malik; Lisa Meng; Jenny Wei; Andrew A. Wolff; Angela Genge; Nicholas E. Johnson; Carolina Tesi-Rocha; Anne M. Connolly; Basil T. Darras; Kevin Felice; Richard S. Finkel; Perry B. Shieh; Jean K. Mah; Jeffrey Statland; Craig Campbell; Ali A. Habib; Nancy L. Kuntz; Maryam Oskoui; John W. Day

doi:10.1007/s13311-021-01120-8

Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study (Neurotherapeutics, (2021), 18, 2, (1127-1136), 10.1007/s13311-020-01004-3)

Stacy A. Rudnicki, Jinsy A. Andrews, Tina Duong, Bettina M. Cockroft, Fady I. Malik, Lisa Meng, Jenny Wei, Andrew A. Wolff, Angela Genge, Nicholas E. Johnson, Carolina Tesi-Rocha, Anne M. Connolly, Basil T. Darras, Kevin Felice, Richard S. Finkel, Perry B. Shieh, Jean K. Mah, Jeffrey Statland, Craig Campbell, Ali A. HabibNancy L. Kuntz, Maryam Oskoui, John W. Day^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

This article has been updated to add the author Richard S. Finkel. The original article has been corrected.

Original language	English (US)
Pages (from-to)	2130
Number of pages	1
Journal	Neurotherapeutics
Volume	18
Issue number	3
DOIs	https://doi.org/10.1007/s13311-021-01120-8
State	Published - Jul 2021

ASJC Scopus subject areas

Pharmacology
Clinical Neurology
Pharmacology (medical)

Access to Document

10.1007/s13311-021-01120-8

Cite this

Rudnicki, S. A., Andrews, J. A., Duong, T., Cockroft, B. M., Malik, F. I., Meng, L., Wei, J., Wolff, A. A., Genge, A., Johnson, N. E., Tesi-Rocha, C., Connolly, A. M., Darras, B. T., Felice, K., Finkel, R. S., Shieh, P. B., Mah, J. K., Statland, J., Campbell, C., ... Day, J. W. (2021). Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study (Neurotherapeutics, (2021), 18, 2, (1127-1136), 10.1007/s13311-020-01004-3). Neurotherapeutics, 18(3), 2130. https://doi.org/10.1007/s13311-021-01120-8

@article{a053a419f37944098f6778ecbe963bc4,

title = "Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study (Neurotherapeutics, (2021), 18, 2, (1127-1136), 10.1007/s13311-020-01004-3)",

abstract = "This article has been updated to add the author Richard S. Finkel. The original article has been corrected.",

author = "Rudnicki, {Stacy A.} and Andrews, {Jinsy A.} and Tina Duong and Cockroft, {Bettina M.} and Malik, {Fady I.} and Lisa Meng and Jenny Wei and Wolff, {Andrew A.} and Angela Genge and Johnson, {Nicholas E.} and Carolina Tesi-Rocha and Connolly, {Anne M.} and Darras, {Basil T.} and Kevin Felice and Finkel, {Richard S.} and Shieh, {Perry B.} and Mah, {Jean K.} and Jeffrey Statland and Craig Campbell and Habib, {Ali A.} and Kuntz, {Nancy L.} and Maryam Oskoui and Day, {John W.}",

note = "Publisher Copyright: {\textcopyright} The American Society for Experimental NeuroTherapeutics, Inc. 2021",

year = "2021",

month = jul,

doi = "10.1007/s13311-021-01120-8",

language = "English (US)",

volume = "18",

pages = "2130",

journal = "Neurotherapeutics",

issn = "1933-7213",

publisher = "Elsevier B.V.",

number = "3",

}

Rudnicki, SA, Andrews, JA, Duong, T, Cockroft, BM, Malik, FI, Meng, L, Wei, J, Wolff, AA, Genge, A, Johnson, NE, Tesi-Rocha, C, Connolly, AM, Darras, BT, Felice, K, Finkel, RS, Shieh, PB, Mah, JK, Statland, J, Campbell, C, Habib, AA, Kuntz, NL, Oskoui, M & Day, JW 2021, 'Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study (Neurotherapeutics, (2021), 18, 2, (1127-1136), 10.1007/s13311-020-01004-3)', Neurotherapeutics, vol. 18, no. 3, pp. 2130. https://doi.org/10.1007/s13311-021-01120-8

Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study (Neurotherapeutics, (2021), 18, 2, (1127-1136), 10.1007/s13311-020-01004-3). / Rudnicki, Stacy A.; Andrews, Jinsy A.; Duong, Tina et al.
In: Neurotherapeutics, Vol. 18, No. 3, 07.2021, p. 2130.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction to

T2 - Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study (Neurotherapeutics, (2021), 18, 2, (1127-1136), 10.1007/s13311-020-01004-3)

AU - Rudnicki, Stacy A.

AU - Andrews, Jinsy A.

AU - Duong, Tina

AU - Cockroft, Bettina M.

AU - Malik, Fady I.

AU - Meng, Lisa

AU - Wei, Jenny

AU - Wolff, Andrew A.

AU - Genge, Angela

AU - Johnson, Nicholas E.

AU - Tesi-Rocha, Carolina

AU - Connolly, Anne M.

AU - Darras, Basil T.

AU - Felice, Kevin

AU - Finkel, Richard S.

AU - Shieh, Perry B.

AU - Mah, Jean K.

AU - Statland, Jeffrey

AU - Campbell, Craig

AU - Habib, Ali A.

AU - Kuntz, Nancy L.

AU - Oskoui, Maryam

AU - Day, John W.

PY - 2021/7

Y1 - 2021/7

N2 - This article has been updated to add the author Richard S. Finkel. The original article has been corrected.

AB - This article has been updated to add the author Richard S. Finkel. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85118339219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118339219&partnerID=8YFLogxK

U2 - 10.1007/s13311-021-01120-8

DO - 10.1007/s13311-021-01120-8

M3 - Comment/debate

C2 - 34731415

AN - SCOPUS:85118339219

SN - 1933-7213

VL - 18

SP - 2130

JO - Neurotherapeutics

JF - Neurotherapeutics

IS - 3

ER -

Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study (Neurotherapeutics, (2021), 18, 2, (1127-1136), 10.1007/s13311-020-01004-3)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this